Quantcast
Home / DC News / Panel urges FDA to loosen Avandia restrictions

Panel urges FDA to loosen Avandia restrictions

WASHINGTON — An advisory panel has urged the Food and Drug Administration to loosen its restrictions on the controversial diabetes drug Avandia, which was nearly wiped from the market in recent years after reports linking it to several heart-related complications.